Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 4
1985 3
1986 3
1987 3
1988 4
1989 3
1990 7
1991 3
1992 2
1993 6
1994 8
1995 10
1996 5
1997 9
1998 8
1999 9
2000 9
2001 12
2002 13
2003 13
2004 10
2005 14
2006 10
2007 13
2008 8
2009 12
2010 17
2011 23
2012 10
2013 13
2014 14
2015 11
2016 24
2017 10
2018 28
2019 11
2020 12
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

334 results
Results by year
Filters applied: . Clear all
Page 1
How we manage Gaucher Disease in the era of choices.
Revel-Vilk S, Szer J, Mehta A, Zimran A. Revel-Vilk S, et al. Among authors: zimran a. Br J Haematol. 2018 Aug;182(4):467-480. doi: 10.1111/bjh.15402. Epub 2018 May 29. Br J Haematol. 2018. PMID: 29808905 Review.
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.
Mehta A, Kuter DJ, Salek SS, Belmatoug N, Bembi B, Bright J, Vom Dahl S, Deodato F, Di Rocco M, Göker-Alpan O, Hughes DA, Lukina EA, Machaczka M, Mengel E, Nagral A, Nakamura K, Narita A, Oliveri B, Pastores G, Pérez-López J, Ramaswami U, Schwartz IV, Szer J, Weinreb NJ, Zimran A. Mehta A, et al. Among authors: zimran a. Intern Med J. 2019 May;49(5):578-591. doi: 10.1111/imj.14156. Intern Med J. 2019. PMID: 30414226 Free PMC article. Review.
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
Biegstraaten M, Cox TM, Belmatoug N, Berger MG, Collin-Histed T, Vom Dahl S, Di Rocco M, Fraga C, Giona F, Giraldo P, Hasanhodzic M, Hughes DA, Iversen PO, Kiewiet AI, Lukina E, Machaczka M, Marinakis T, Mengel E, Pastores GM, Plöckinger U, Rosenbaum H, Serratrice C, Symeonidis A, Szer J, Timmerman J, Tylki-Szymańska A, Weisz Hubshman M, Zafeiriou DI, Zimran A, Hollak CEM. Biegstraaten M, et al. Among authors: zimran a. Blood Cells Mol Dis. 2018 Feb;68:203-208. doi: 10.1016/j.bcmd.2016.10.008. Epub 2016 Oct 24. Blood Cells Mol Dis. 2018. PMID: 28274788 Free article.
The definition of neuronopathic Gaucher disease.
Schiffmann R, Sevigny J, Rolfs A, Davies EH, Goker-Alpan O, Abdelwahab M, Vellodi A, Mengel E, Lukina E, Yoo HW, Collin-Histed T, Narita A, Dinur T, Revel-Vilk S, Arkadir D, Szer J, Wajnrajch M, Ramaswami U, Sidransky E, Donald A, Zimran A. Schiffmann R, et al. Among authors: zimran a. J Inherit Metab Dis. 2020 Sep;43(5):1056-1059. doi: 10.1002/jimd.12235. Epub 2020 Apr 3. J Inherit Metab Dis. 2020. PMID: 32242941 Free PMC article.
Impact of Gaucher disease on COVID-19.
Zimran A, Szer J, Revel-Vilk S. Zimran A, et al. Intern Med J. 2020 Jul;50(7):894-895. doi: 10.1111/imj.14894. Intern Med J. 2020. PMID: 32656977 Free PMC article. No abstract available.
Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
Elstein D, Mellgard B, Dinh Q, Lan L, Qiu Y, Cozma C, Eichler S, Böttcher T, Zimran A. Elstein D, et al. Among authors: zimran a. Mol Genet Metab. 2017 Sep;122(1-2):113-120. doi: 10.1016/j.ymgme.2017.08.005. Epub 2017 Aug 24. Mol Genet Metab. 2017. PMID: 28851512 Free article. Clinical Trial.
334 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page